Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

71
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
71
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

429
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
429
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

500
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
500
Mitochondrial Membranes01:45

Mitochondrial Membranes

8.1K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptional Profiling Shows Dampening of Interferon Gene Signatures by NAD<sup>+</sup> Augmentation in Ataxia-Telangiectasia.

International journal of molecular sciences·2026
Same author

Plasma serine and glycine in relation to clinical outcomes following neoadjuvant radiotherapy for rectal cancer.

Clinical and translational radiation oncology·2026
Same author

Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitis.

Journal of hepatology·2026
Same author

Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver disease.

Gut microbes·2026
Same author

Disentangling the gut microbiome and inflammation in inflammatory bowel diseases: longitudinal observations from the IBSEN III study.

Inflammatory bowel diseases·2026
Same author

Proctocolectomy with permanent ileostomy is associated with improved transplant-free survival in patients with PSC.

JHEP reports : innovation in hepatology·2026

Related Experiment Video

Updated: Jun 3, 2025

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.7K

Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitis.

Guri Fossdal1,2,3, Peder Braadland1,4,5, Johannes Roksund Hov1,4,5,6

  • 1Norwegian PSC Research Centre, Department of Transplantation Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway.

Scandinavian Journal of Gastroenterology
|January 7, 2025
PubMed
Summary

Mitochondrial dysfunction is prominent in primary sclerosing cholangitis (PSC), particularly with cholestasis. This study characterized molecular indicators of impaired mitochondrial function in PSC patients, revealing potential links to disease severity.

Keywords:
Primary sclerosing cholangitisbiomarkerfatty acidsfibrosismitochondrial dysfunction

More Related Videos

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.5K
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

15.5K

Related Experiment Videos

Last Updated: Jun 3, 2025

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.7K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.5K
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

15.5K

Area of Science:

  • Hepatology
  • Mitochondrial Biology
  • Biochemistry

Background:

  • Mitochondrial dysfunction is a hallmark of many liver diseases.
  • Data on mitochondrial dysfunction in primary sclerosing cholangitis (PSC) is limited.
  • Understanding mitochondrial function in PSC is crucial for disease management.

Purpose of the Study:

  • To comprehensively characterize mitochondrial dysfunction in PSC.
  • To determine if mitochondrial dysfunction in PSC is specific or associated with cholestasis.
  • To analyze circulating and liver-resident molecules reflecting mitochondrial dysfunction.

Main Methods:

  • Retrospective analysis of plasma and liver tissue from PSC patients and controls.
  • Mass spectrometry profiling of lipids, fatty acids, carnitines, acylcarnitines, and tryptophan-kynurenine pathway metabolites.
  • Hierarchical clustering of fatty acid levels to differentiate patient groups.

Main Results:

  • PSC patients showed distinct fatty acid profiles compared to controls, with altered monounsaturated fatty acids (MUFA) and saturated fatty acids (SFAs).
  • Elevated acylcarnitine ratios indicated impaired mitochondrial fatty acid oxidation in PSC.
  • Tryptophan-kynurenine pathway alterations suggested impaired NAD biosynthesis and mitochondrial energy supply.

Conclusions:

  • Mitochondrial dysfunction is prominent in PSC and correlates with the severity of cholestasis.
  • The findings suggest mitochondrial dysfunction may be a marker or driver of PSC.
  • Further research is needed to explore therapeutic targets related to mitochondrial function in PSC.